Plantrix Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 4.50 M
- Revenue Growth 15.51%
- Profit Growth 277.80%
- Ebitda 126.40%
- Net Worth 78.07%
- Total Assets 1.96%
About Plantrix Biotech
Plantrix Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 September 2017 (Seven years and five months 2 days old ). Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hrushikesh Landge and Jayshri Landge serve as directors at the Company.
Company Details
-
Location
Ahmed Nagar, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299PN2017PTC172474
-
Company No.
172474
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Sep 2017
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Plantrix Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hrushikesh Landge
|
Director | 12-Sep-2017 | Current |
|
Jayshri Landge
|
Director | 12-Sep-2017 | Current |
Financial Performance of Plantrix Biotech.
Plantrix Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.51% increase. The company also saw a substantial improvement in profitability, with a 277.8% increase in profit. The company's net worth Soared by an impressive increase of 78.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plantrix Biotech?
In 2018, Plantrix Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.50 M
Charges Breakdown by Lending Institutions
- Others : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2018 | Others | ₹4.50 M | Satisfied |
How Many Employees Work at Plantrix Biotech?
Unlock and access historical data on people associated with Plantrix Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plantrix Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plantrix Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
